Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The checkpoint inhibitor TTI-621 (SIRPαFc) stimulates innate and adaptive immune responses in patients with hematologic and solid tumor malignancies
    Meeting Abstract

    Johnson, L.; Ansell, S.; Chen, R.; Flinn, I.; Maris, M.; O'Connor, O.; Lesokhin, A.; Thompson, J.; Akilov, O.; Querfeld, C.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Chimeric antigen receptors: A paradigm shift in immunotherapy
    Journal Article

    Sadelain, M.
    Annual Review of Cancer Biology (2017)

    Fulltext@MSK | Save
  • Hormone replacement therapy and risk of multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS) and MGUS progression in the UK Clinical Practice Research Datalink
    Meeting Abstract

    Bradley, M. C.; McShane, C.; Hughes, C. M.; Landgren, O.; Murray, L.; Anderson, L. A.
    Pharmacoepidemiology and Drug Safety (2017)

    Fulltext@MSK | Save
  • Spliceosomal dysfunction Is a critical mediator of IDH2 mutant leukemogenesis
    Meeting Abstract

    Yoshimi, A.; Lin, K. T.; Wiseman, D.; Intlekofer, A. M.; Wang, B.; Pastore, A.; Rahman, M.; Lee, S. C. W.; Liu, B.; Micol, J. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Hsp90 facilitates oncogene-induced metabolic reprogramming in B-cell lymphomas
    Meeting Abstract

    Vidal, M. N. C.; Krumsiek, J.; Patel, J.; Yang, S. N.; Phillip, J. M.; Marullo, R.; Taldone, T.; Inghirami, G.; Melnick, A.; Chiosis, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • m(6)A regulates differentiation state and mRNA translation in myeloid leukemia
    Meeting Abstract

    Vu, L. P.; Pickering, B. F.; Cheng, Y.; Sara, Z.; Nguyen, D.; Minuesa, G.; Chou, T.; Chow, A.; MacKay, M.; Famulare, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Generation of clonal antigen specific CD8αβ(+) cytotoxic T lymphocytes from renewable pluripotent stem cells for off-the-shelf T cell therapeutics
    Meeting Abstract

    Van Der Stegen, S.; Clarke, R.; Mansilla-Soto, J.; Ortiz, E.; Chang, C. W.; Sasaki, J.; Lee, T.; Lan, W.; Shoemaker, D.; Riviere, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Targeting PRMT1 as a novel curative therapy for acute myeloid leukemia
    Meeting Abstract

    Su, H.; Jin, S.; Shen, Y.; Kutny, M. A.; Jin, J.; Luo, M.; Zhao, X.
    Blood (2017)

    Fulltext@MSK | Save
  • High-resolution CRISPR functional genomics reveals critical vulnerabilities of the NuRD complex for fetal hemoglobin control
    Meeting Abstract

    Sher, F.; Schoonenberg, V.; Cole, M. A.; Macias-Trevino, C.; Cifani, P.; Schupp, P. G.; Canver, M. C.; Kurita, R.; Nakamura, Y.; Orkin, S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save